Sep 27, 2018 - Aldeyra Therapeutics' (ALDX) dry eye candidate, reproxalap, achieves early onset of improvement in patients and a broad range of activity.
Sep 19, 2018 - AbbVie's (ABBV) shares fall on a lawsuit by California insurance department accusing it of giving illegal kickbacks to doctors for prescribing Humira.
Sep 14, 2018 - The FDA confers fast track designation on Ironwood's (IRWD) praliciguat for the treatment of heart failure with preserved ejection fraction.
Sep 14, 2018 - Let's see if Allergan (AGN) stock is a good choice for value-oriented investors right now from multiple angles.
Sep 05, 2018 - Allergan PLC (NYSE:AGN) 2018 Wells Fargo Healthcare Conference Call September 05, 2018 09:05 AM ET Executives Brent Saunders - Chief Executive Officer Analysts David Maris - Wells Fargo Securities Pre
Aug 10, 2018 - BioDelivery Sciences (BDSI) reports narrower-than-expected loss in Q2. Sales marginally miss the consensus mark.
Aug 10, 2018 - Novo Nordisk (NVO) reports strong Q2 results. J&J (JNJ) seeks approval for new dosing regimen of multiple myeloma drug. Allergan (AGN) exercises option to buy Editas' lead ocular candidate.
Jul 25, 2018 - Let's see how these five pharma/biotech stocks are poised ahead of their scheduled results on Jul 26.
Jul 24, 2018 - The FDA grants fast track designation to Allergan's (AGN) AGN-241751, developed for the treatment of patients with major depressive disorder.
Jul 23, 2018 - The FDA designates Allergan's (NYSE:AGN) Phase 2-stage AGN-241751 for Fast Track review for the treatment of major depressive disorder (MDD).The company acquired the NMDAR modulator from Aptin